Sichuan Hebang Biotechnology Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Huirong Yang

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	7yrs
Participación del CEO	0.002%
Permanencia media de la dirección	12.1yrs
Promedio de permanencia en la Junta Directiva	7.5yrs

Actualizaciones recientes de la dirección

Recent updates

Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?

Mar 07

Here's Why I Think Sichuan Hebang Biotechnology (SHSE:603077) Is An Interesting Stock

Apr 21

CEO

Huirong Yang (57 yo)

7yrs

Permanencia

CN¥931,400

Compensación

Ms. Huirong Yang has been the General Manager of Sichuan Hebang Biotechnology Corporation Limited since May 25, 2017 and served as its Supervisor since March 2011 until May 25, 2017.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Huirong Yang	General Manager	7yrs	CN¥931.40k	0.0024% CN¥ 419.9k
Jun Wang	CFO, Deputy GM & Director	16.3yrs	CN¥706.60k	0.036% CN¥ 6.2m
Rong Mo	Secretary & Director	16.3yrs	CN¥725.00k	0.036% CN¥ 6.2m
Anping Liu	Deputy General Manager	8yrs	CN¥382.30k	sin datos

12.1yrs

Permanencia media

53.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 603077 es experimentado (12 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Jun Wang	CFO, Deputy GM & Director	16.3yrs	CN¥706.60k	0.036% CN¥ 6.2m
Rong Mo	Secretary & Director	16.3yrs	CN¥725.00k	0.036% CN¥ 6.2m
Changhua Yuan	Independent Director	4yrs	sin datos	sin datos
Zhenggang He	Director	16.3yrs	CN¥1.04m	4.99% CN¥ 866.5m
Hongwu Yang	Director	11.3yrs	CN¥217.70k	0.035% CN¥ 6.1m
Chengyun Miao	Chairman of the Supervisory Board	16.3yrs	sin datos	sin datos
Xiaoping Zeng	Chairman	8yrs	CN¥1.13m	sin datos
Shuxian Mei	Independent Director	7yrs	sin datos	sin datos
Changhua Yuan	Independent Director	4yrs	CN¥100.00k	sin datos
Xueling Qin	Director	3yrs	CN¥100.00k	0.000050% CN¥ 8.7k
Yang Hu	Independent Director	4yrs	CN¥100.00k	sin datos
Rongpeng Gong	Employee Representative Supervisor	7yrs	sin datos	sin datos

7.5yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: La junta directiva de 603077 se considera experimentada (7.4 años de antigüedad promedio).

Sichuan Hebang Biotechnology Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Sichuan Hebang Biotechnology Corporation Limited, Annual General Meeting, May 15, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Sichuan Hebang Biotechnology Corporation Limited, Annual General Meeting, May 15, 2024

First quarter 2024 earnings released: EPS: CN¥0.004 (vs CN¥0.046 in 1Q 2023)

Sichuan Hebang Biotechnology Corporation Limited to Report Q1, 2024 Results on Apr 27, 2024

Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?

Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077) announces an Equity Buyback for CNY 400 million worth of its shares.

Sichuan Hebang Biotechnology Corporation Limited to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: EPS: CN¥0.046 (vs CN¥0.092 in 3Q 2022)

Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077) announces an Equity Buyback for CNY 400 million worth of its shares.

Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077) announces an Equity Buyback for CNY 400 million worth of its shares.

New minor risk - Profit margin trend

Sichuan Hebang Biotechnology Corporation Limited to Report First Half, 2023 Results on Aug 30, 2023

First quarter 2023 earnings released: EPS: CN¥0.046 (vs CN¥0.12 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.36 in FY 2021)

Price target increased to CN¥6.00

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.092 (vs CN¥0.13 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.078 in 2Q 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Here's Why I Think Sichuan Hebang Biotechnology (SHSE:603077) Is An Interesting Stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.03 loss in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.078 (vs CN¥0.009 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.004 loss in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.005 (vs CN¥0.06 in FY 2019)

New 90-day high: CN¥1.57

New 90-day low: CN¥1.32

New 90-day low: CN¥1.33

New 90-day high: CN¥1.52

Third quarter earnings released

New 90-day low: CN¥1.34

SichuanHebang Biotechnology Co.,Ltd. to Report Q3, 2020 Results on Oct 30, 2020

New 90-day high - CN¥1.63

First half earnings released

New 90-day high - CN¥1.48

SichuanHebang Biotechnology Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad